Official 2024 U.S. DOL Form 5500 summary for Lovelace Biomedical Research Institute (Lovelace Biomedical Research Institute Tda And Dc Plan · EIN 85-0110669 · PN 001): $122.76M net assets, 407 active participants, and $13.68 per $10,000 (13.68 bps).
| Plan Sponsor | Lovelace Biomedical Research Institute |
|---|---|
| Filing Identifier | Lovelace Biomedical Research Institute Tda And Dc Plan · EIN 85-0110669 · PN 001 |
| Plan Category & State | 403(b) Tax-Exempt DC (NM) |
| Asset-Size Peer Cohort | $100M-$500M |
| Plan Net Assets (2024) | $122.76M |
| Active Participants | 407 |
| Direct Admin Fee Rate | $13.68 per $10,000 (13.68 bps) |
| Cohort Peer Median | $9.75 per $10,000 (9.75 bps) |
| Primary Recordkeeper / Provider | TIAA |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI